Clinical trial
The Clinical Evaluation of the MDT-4107 Drug-Eluting Coronary Stent in De Novo Lesions in Native Coronary Arteries
NCT00927940 is registered in ClinicalTrials.gov with Medtronic Vascular as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Clinical Evaluation of the MDT-4107 Drug-Eluting Coronary Stent in De Novo Lesions in Native Coronary Arteries
- Lead sponsor
- Medtronic Vascular
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 31, 2009
- Completion date
- February 28, 2015
- Enrollment
- 100 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.